Nano Science and Technology Institute - NSTI  
Nano Science and Technology Institute   Home | Subscribe | Site Map  
  ABOUT | COURSES | EVENTS | PUBLICATIONS | LEADERSHIP | OUTREACH | NEWS | PRESS | JOBS | Nanotechnology Solutions
px
px fade_top
Publications
Nanotech 2008 CDROM
Nanotech 2007 CDROM
Nanotech 2006 CDROM
Nanotech 2005 CDROM
Nanotech 2004 CDROM
3 CDROM Special Offer
Nanotech 2008 Vol. 1
Nanotech 2008 Vol. 2
Nanotech 2008 Vol. 3
Nanotech 2007 Vol. 1
Nanotech 2007 Vol. 2
Nanotech 2007 Vol. 3
Nanotech 2007 Vol. 4
Nanotech 2006 Vol. 1
Nanotech 2006 Vol. 2
Nanotech 2006 Vol. 3
Nanotech 2005 Vol. 1
Nanotech 2005 Vol. 2
Nanotech 2005 Vol. 3
WCM 2005
Nanotech 2004 Vol. 1
Nanotech 2004 Vol. 2
Nanotech 2004 Vol. 3
Nanotech 2003 Vol. 1
Nanotech 2003 Vol. 2
Nanotech 2003 Vol. 3
Nanotech 2002 Vol. 1
Nanotech 2002 Vol. 2
Nanotech 2001 Vol. 1
Nanotech 2001 Vol. 2
MSM 2000
MSM 99
MSM 98
Index of Authors
Index of Keywords
Index of Affiliations
Library Request Form
Shopping Cart
Order Form
 
Publications Publications
Nanotech 2007 Vol. 2
p
 
Technical Proceedings of the 2007 NSTI Nanotechnology Conference and Trade Show, Volume 2
Nanotech 2007 Vol. 2
Technical Proceedings of the 2007 NSTI Nanotechnology Conference and Trade Show, Volume 2
 
Chapter 4: Biomarkers & Nanoparticles
 

Differential Uptake of PEG-Silica-FITC Nanoparticles by Human Breast Cancer Cells and Normal Human Breast Epithelial Cells

Authors:N. Iwakuma, P. Sharma, M.J. Delano, L.L. Moldawer, B.M. Moudgil and S.R. Grobmyer
Affilation:University of Florida, US
Pages:348 - 351
Keywords:silica nanoparticles, breast cancer, normal breast epithelial cells, cellular uptake, flow cytometry
Abstract:Background: An understanding of uptake of nanoparticles (NPs) by human cancer cells and non-cancer cells is important for the development of NPs as novel cancer therapeutic and diagnostic agents. Hypothesis: Uptake of NPs is increased in human breast cancer cells compared to normal human breast epithelial cells. Methods: PEGylated-FITC silica NPs (150nm, [1.18mg/mL]) were synthesized. Human breast cancer cell lines (MCF-7, BT474) and normal human breast epithelial cells were (MCF10A) cultured. Cells were exposed to NPs for 24h. A quantitative analysis (Flow-Cytometry) and qualitative analysis of cellular uptake (Fluorescence microscopy) were performed. Results: Exposure of cells to NPs did not affect cell viability. After incubation of cells with 20 l of NPs, increased uptake of PEG-silica-FITC NPs was seen in cancer cells (MCF-7, 18.5%; BT474, 16.8%) compared to non-cancer cells (MCF-10A, 9.9%). Incubation of cells with 40 l of NPs demonstrated that uptake of NPs is dose related and confirmed preferential uptake of NPs by cancer cells (MCF-7, 27.3%; BT474, 25.2%) compared to non-cancer cells (MCF-10A, 12.3%). Conclusion: Human breast cancer cells demonstrate increased uptake of NPs compared to normal human breast epithelial cells. This observation has important implications for the development of NPs as cancer therapeutic and/or diagnostic agents.
ISBN:1-4200-6183-6
Pages:838
Hardcopy:$199.99
 
Order:Mail/Fax Form
Special:3 CD Set — 15% off with Free Shipping
Up
Upcoming Events
Nanotech 2009
Cleantech 2009
BioNano 2009
TechConnect Summit
nanoPRwire™
nanoPRwire
News Headlines
nano World news
 
 
 
 
px
© Nano Science and Technology Institute     About NSTI | Terms of Use | Privacy Policy | Contact